Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Zsuzsanna Szent-Királlyi is active.

Publication


Featured researches published by Zsuzsanna Szent-Királlyi.


Journal of Pharmaceutical and Biomedical Analysis | 2008

Evaluation of the composition of the binder bridges in matrix granules prepared with a small-scale high-shear granulator

János Bajdik; Gabriella Baki; Zsuzsanna Szent-Királlyi; Klaus Knop; Peter Kleinebudde; Klára Pintye-Hódi

The aim of this work was to evaluate the binder bridges which can form in hydrophilic matrix granules prepared with a small-scale high-shear granulator. Matrices contained hydroxypropyl methylcellulose (HPMC) as a matrix-forming agent, together with lactose monohydrate and microcrystalline cellulose as filler. Water was used as granulating liquid. A 2(4) full factorial design was used to evaluate the effects of the operational parameters (impeller speed, chopper speed, dosing speed and wet massing time) on the granulation process. The temperature of the sample increased relevantly during the preparation in the small-scale apparatus. The same setup induced different temperature increases for different amounts of powder. This alteration enhances the solubility of lactose and decreases that of HPMC, and thus the quantities of the dissolved components can vary. Accordingly, changes in composition of the binder bridge can occur. Since exact determination of the dissolution of these materials during granulation is difficult, the consequences of the changes in solubility were examined. Differential scanning calorimetry (DSC), thermomechanical analysis (TMA) and X-ray diffraction (XRD) measurements were made to evaluate the films prepared from liquids with different ratios of soluble materials. The DSC and XRD measurements confirmed that the lactose lost its crystalline state in the film. The TMA tests revealed that increase of the quantity of lactose in the film decreased the glass transition temperature of the film; this may be attributed to the interaction of the additives. At a lactose content of 37.5%, a second glass transition appeared. This phenomenon may be indicative of a separate amorphous lactose phase.


Archive | 2006

New Crystalline Atorvastatin Hemicalcium Salt Polymorph Form

Jozsef Barkoczy; Nagy Peter Kotay; Gyula Simig; Judit Cselenyak; Zsuzsanna Szent-Királlyi; Ferenc Bartha; Zoltán Katona; Donáth Györgyi Vereczkeyné; Kalman Nagy; Norbert Nemeth; György Ruzsics


Archive | 2005

New pseudopolymorph of desloratadine formed with carbon dioxide

Fekete Valeria Hofmanne; Gyula Lukács; Tibor Mezei; Enikö Molnár; Márta Porcs-Makkay; Gyula Simig; Zsuzsanna Szent-Királlyi; Balázs Volk


Archive | 2004

Process for the preparation of crystalline polymorph of a platelet aggregation inhibitor drug

Gyorgyi Vereczkeyne Donath; Kalman Nagy; Gyuláné Körtvélyessy; Zsuzsanna Szent-Királlyi; Peter Kotay Nagy; Gyula Simig; Jozsef Barkoczy; Tamás Gregor; Béla Farkas


Archive | 2009

New polymorph and amorphous forms of desvenlafaxine fumarate

László Pongó; Gyula Simig; Jozsef Barkoczy; Balázs Volk; András Dancsó; Zsuzsanna Szent-Királlyi; Adrienn Hegedűs; Lmre Markovits; Tamás Gregor; László Százdi; György Ruzsics; Kalman Nagy; József Debreczeni


Archive | 2006

Process for the preparation of olanzapine

Gyorgyi Kovanyine Lax; Gábor Németh; György Krasznay; Norbert Mesterhazy; Kalman Nagy; Gyorgyi Vereczkeyne Donath; Zsuzsanna Szent-Királlyi


Archive | 2012

NEW SALTS, POLYMORPHS AND SOLVATES OF FEBUXOSTAT

László Pongó; Balázs Volk; Jozsef Barkoczy; András Dancsó; Gyula Lukács; Gyula Simig; László Százdi; Peter Tompe; György Ruzsics; Zsuzsanna Szent-Királlyi


Archive | 2010

Process for preparing pharmaceutical compounds and intermediate compounds

Márta Porcs-Makkay; Balázs Volk; Tamás Gregor; Jozsef Barkoczy; Tibor Mezei; Judit Broda; Bálint Nyulasi; György Ruzsics; Enikö Molnár; József Debreczeni; Kalman Nagy; Angéla Pandur; Zsuzsanna Szent-Királlyi


Archive | 2009

Crystalline form i rosuvastatin zinc salt

Feren Bartha; Lax Györgyi Koványiné; Balázs Volk; Jozsef Barkoczy; György Morovján; György Krasznai; Kalman Nagy; Gyula Simig; György Ruzsics; György Clementis; Imre Kapui; Péter Slégel; Adrienn Keszthelyi; Zsuzsanna Szent-Királlyi; Fekete Valéria Hoffmanné; Janos Imre


Archive | 2004

Process for the preparation of amorphous form of a platelet aggregation inhibitor drug

Peter Kotay Nagy; Gyula Simig; Jozsef Barkoczy; Tamás Gregor; Béla Farkas; Gyorgyi Vereczekeyne Donath; Kalman Nagy; Gyuláné Körtvélyessy; Zsuzsanna Szent-Királlyi

Collaboration


Dive into the Zsuzsanna Szent-Királlyi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Balázs Volk

Hungarian Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Balázs Volk

Hungarian Academy of Sciences

View shared research outputs
Researchain Logo
Decentralizing Knowledge